OpenAlex
PricingAboutJobs
Log inGet started
Work

Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus

HTML

Year: 2016
Type: review
Source: Postgraduate Medicine
DOI: 10.1080/00325481.2017.1256747
Authors: Thomas C. Blevins, Azeez Farooki
Institutions: Texas Diabetes & Endocrinology, Memorial Sloan Kettering Cancer Center
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: canagliflozin, SGLT2 inhibitors, type 2 diabetes, bone mineral density, fracture risk, bone resorption markers, β-CTX, osteocalcin, weight loss, CANVAS trial
SDG: Good health and well-being

Open Access status: closed

Funder: Janssen Research and Development
OpenAlex ID: W2558297083
FWCI: 1.174
Cites: 89
Cited by: 48
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security